Abstract
I would like to comment on the report, "Split Products of Fibrin in Newborns," by Drs. Stiehm and Clatanoff. We have examined over 50 specimens of cord serum from babies delivered normally or by uncomplicated cesarean section, and have been unable to detect increased levels of fibrin degradation products (F.D.P.) in any of the samples. The technique used is a modification of the Tanned Red Cell Hemagglutination Inhibition Immunoassay (TRCHII) described by Merskey, Kleiner and Johnson.1
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
